Rapid review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS)

Public consultation on the rapid review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS) is now open via the Department’s Consultation Hub. Consumers, organisations, health professionals, pharmaceutical companies and interested members of the public are invited to provide comments on the review’s research questions. Consultation will close on 1 October 2026.